Loading...
Bunge Global Ltd (BG) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has positive analyst ratings and potential growth catalysts, the recent financial performance, technical indicators, and lack of strong proprietary trading signals suggest waiting for a clearer entry point.
The MACD is negatively expanding (-0.773), indicating bearish momentum. RSI is neutral at 40.367, and while moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the stock is trading below key pivot support levels (S1: 119.094, S2: 117.546). This suggests potential downside risk in the short term.

Analysts have raised price targets significantly, with a consensus range of $130-$145, citing strong Q4 performance, potential synergies from the Viterra merger, and multiple growth levers. Hedge funds and insiders remain neutral, indicating no significant selling pressure.
The company's Q4 financials showed a sharp decline in net income (-84.22% YoY), EPS (-88.76% YoY), and gross margin (-43.71% YoY), which raises concerns about profitability. The stock is also underperforming in the short term, with a -1.61% regular market change and -0.81% post-market change.
In Q4 2025, revenue increased significantly by 75.47% YoY to $23.76 billion, driven by strong performance in the Soybean and Oilseeds Processing segments. However, net income dropped sharply to $95 million (-84.22% YoY), and EPS fell to 0.49 (-88.76% YoY), indicating profitability challenges despite revenue growth.
Analysts are bullish on the stock, with multiple firms raising price targets to $130-$145 and maintaining Buy or Overweight ratings. They cite strong Q4 results, potential synergies from the Viterra merger, and growth levers as reasons for optimism. However, some caution remains due to uncertainties around biofuel policy.